Healthy male/female adults
Conditions
Interventions
Single ingestion of the test food - single ingestion of the placebo food.
Single ingestion of the placebo food - single ingestion of the test food.
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy males and females aged over 20 to under 65 when informed consent. (2) Subjects with saliva secretion (Saxon method) of over 2 g to under 6 g at preliminary examination (3) Subjects who have received enough explanation and understood about this study, and who can obtain informed consent documents.
Exclusion criteria
Exclusion criteria: (1)Subjects equipped with full/partial dentures, or being in the process of straightening their teeth, or stinging their teeth by sweet foods. (2)Subjects who have been to the hospital for treatment or oral cleaning within one month prior to the beginning of the test, or those who are planning to visit the hospital before the end of the test. (3)Throughout this trial, subjects who have any difficulty in refraining from taking steadily (not less than 3 times a week) in the medicines, health-specific/functional/health foods (related to salivary secretion, halitosis control, and immunity), which might affect the test results. (4)Subjects falling into the habit of smoking (rough average: not less than 20 cigarettes/day) (5)Subjects with probable seasonal allergy just like pollinosis, during the test period. (6)Subjects whose life style will change during the test period. (7) Subjects receiving some kind of medical treatment (especially in Sjogren's syndrome etc.) (8)Subjects with previous/current medical history of digestive diseases (concerning the previous one, non-influential those in participating in this trial, may be accepted judging from the principal investigator.) (9)Subjects who were hospitalized and received treatment in the past 6 months, or will be hospitalized during the test period. (10)Pregnant, possibly pregnant, lactating women. (11)Subjects with previous/current medical history of serious diseases in heart, liver, kidney etc. (12)Subjects with excessive alcohol intakes (tentative average: more than 60 g/day in a week). (13)Subjects having drug/food allergy. (14)Subjects who are now under the other clinical trials with some kind of medicine/food, or participated in those within 4 weeks prior to this study, or are planning to join those after giving informed consent to take part in this study. (15)Others who have been determined as ineligible for participation, according to the principal/sub investigator's opinion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Saliva-related parameters | — |
Countries
Japan
Contacts
Public ContactShinpei Kawakami
Morinaga & Co., Ltd. Health Science and Research Center, R&D institute
Outcome results
None listed